A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
11/2004
11/04/2004	CA2522354A1 8beta-vinyl-11beta-(alpha-substituted)alkyl-estra-1,3,5(10)-trienes
11/04/2004	CA2519164A1 Compositions comprising hyaluronic acid for the prevention of urogenital infections
11/03/2004	EP1473365A1 Angiogenesis inhibitors
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473295A1 Fused bicyclic pyrimidine derivatives
11/03/2004	EP1473034A1 Use of an inhibitor of the phosphodiesterase-4-enzyme (PDE4) alone or in combination with relaxin and derivatives thereof for the manufacture of a medicament to promote decidualization of endometrial cells and to increase fertility
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472255A1 Aza-arylpiperazines
11/03/2004	EP1472250A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1471941A1 Method of treatment of vulval vestibulitis
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471917A1 Use of pde5 inhibitors such as sildenafil in the treatment of polycystic ovary syndrome
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471891A2 Polymer-based compositions for sustained release
11/03/2004	EP1471890A2 Pharmaceutical dosage form for mucosal delivery
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004	EP1261609B1 Triazolotriazinones and the use thereof
11/03/2004	EP1207884B1 Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP1094831A4 Compositions and methods for in vitro fertilization
11/03/2004	EP0877748B1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
11/03/2004	EP0788305B1 Composition for inactivating irritants in fluids
11/03/2004	CN1543473A Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
11/03/2004	CN1543467A Diazacycloalkanes as oxytocin agonists
11/03/2004	CN1543461A Melanocortin receptor ligands
11/03/2004	CN1543456A Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/03/2004	CN1543451A Receptor modulators activated by peroxizonal proliferators (ppar)
11/03/2004	CN1542010A Azolo triazines and pyrimidines
11/03/2004	CN1541678A Mastoplasia treating medicine
11/03/2004	CN1541673A Kidney nourishing medicated wine
11/03/2004	CN1541659A Application of botanical medicinal composition in the preparation of gynecopathy treating medicine
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173964C Novel benzofuranone derivative and process for producing same
11/03/2004	CN1173706C Application of N-acetyl-D-aminoglucose in preparing medicines to treat cervical erosion
11/03/2004	CN1173700C Compositions and methods for amelioration of human female sexual dysfunction
11/03/2004	CN1173635C Natural tea for curing men's impotence and method for manufacturing the same
11/02/2004	US6812253 4-Fluoro-N-indan-2-yl benzamide and its use as a pharmaceutical
11/02/2004	US6812236 Compounds useful in therapy
11/02/2004	US6812225 Pyschological disorders; antidepressants
11/02/2004	CA2315614C Pyrazoles
11/02/2004	CA2296970C Neuropeptide y antagonists
10/2004
10/28/2004	WO2004092215A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2
10/28/2004	WO2004092199A2 Method for identifying modulators of g protein coupled receptor signaling
10/28/2004	WO2004091641A1 Follicle-stimulating hormone releasing agent
10/28/2004	WO2004091635A1 Remedy for endometriosis and gynecologic diseases
10/28/2004	WO2004091628A1 Receptor antagonist
10/28/2004	WO2004075823A8 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
10/28/2004	WO2004064716A3 Eicosapentaenoic acid and docosapentaenoic acid for treating inflammatory disorders
10/28/2004	WO2003086298A3 Use of interleukin-19 to treat ovarian cancer
10/28/2004	WO2003030833A3 Angiopoietin-2 specific binding agents
10/28/2004	WO2001081540A3 Growth factor which acts through erb b-4 rtk
10/28/2004	US20040215018 use as selective estrogen receptor modulators, and use in inhibiting bone loss, cardiovascular disease, and breast and uterine carcinoma
10/28/2004	US20040215014 Auroyl cyclic amines for controlling behavior or appetite
10/28/2004	US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004	US20040214875 Imidazolinylmethyl aralkylsulfonamides
10/28/2004	US20040214864 Novel compounds
10/28/2004	US20040214831 cGMP PDE 5 inhibitors for inhalation in the treatment of sexual dysfunction
10/28/2004	US20040214830 2,7-Substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors
10/28/2004	US20040214826 Method of treating sexual disturbances
10/28/2004	US20040214825 Method of treating sexual disturbances
10/28/2004	US20040214824 treating sexual disorders using (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione
10/28/2004	US20040214823 Administering a fused aminoquinoline derivative such as (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo(4,5,1-ij) quinoline-2(1H)-thione
10/28/2004	US20040214815 Therapeutic compounds
10/28/2004	US20040214814 Pyrazole compounds useful as protein kinase inhibitors
10/28/2004	US20040214759 Compositions and methods of use for a fibroblast growth factor
10/28/2004	US20040214331 Transforming and propagating viral-like particle in cells; for use as tools in prevention and treatment of viral infection; viricides and genetic vaccines
10/28/2004	US20040214158 Treatment of human papillomavirus (hpv)-infected cells
10/28/2004	US20040213797 Conjugates for the modulation of immune responses
10/28/2004	CA2522076A1 Method for identifying modulators of g protein coupled receptor signaling
10/27/2004	EP1471147A2 Method of making a recombinant molecule for the expression of HPV-16 L1 protein
10/27/2004	EP1471056A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same
10/27/2004	EP1471055A1 6-phenylpyridyl-2-amine derivatives
10/27/2004	EP1470239A2 Psoriasin expression by breast epithelial cells
10/27/2004	EP1470155A2 Pluripotency determining factors and uses thereof
10/27/2004	EP1470153A2 Two gonadotropin releasing hormones and a method to isolate the same
10/27/2004	EP1470150A2 Corticosteroids nitrate derivatives
10/27/2004	EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
10/27/2004	EP1470124A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
10/27/2004	EP1470122A1 Rho-kinase inhibitors
10/27/2004	EP1470121A1 Pyrimidine derivatives as rho-kinase inhibitors
10/27/2004	EP1470115A1 Treatment of male sexual dysfunction
10/27/2004	EP1470112A1 Substituted pyridazinones as inhibitors of p38
10/27/2004	EP1469878A2 Fgfr agonists
10/27/2004	EP1469861A1 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen
10/27/2004	EP1469857A1 Use of pde5 inhibitors in the treatment of scarring and fibrosis
10/27/2004	EP1469851A1 Melanocortin receptor agonists
10/27/2004	EP1469846A2 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
10/27/2004	EP1373263B1 Heterocyclic compounds for aging-related and diabetic vascular complications
10/27/2004	EP1150574B1 A natural tea for curing men's impotence and a method for manufacturing the same
10/27/2004	EP0831791B1 Delivery of drugs to the lower gi tract
10/27/2004	CN1541335A EPF receptor assays, compounds and therapeutic compsns.
10/27/2004	CN1541262A Hops extracts, method for prodn. and use
10/27/2004	CN1541224A Antagonistic anti-hTNFSF13b Human antibodies
10/27/2004	CN1541220A 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents
10/27/2004	CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same

1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 557